Articles

Cambria Investment’s Faber tells MarketWatch how he makes shareholders money by owning high-quality, dividend-paying stocks that most investors overlook.

Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the company’s medical-devices business.

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

The U.S. import price index fell 0.4% in September, the Labor Department said Wednesday. This is the second straight monthly decline due to lower fuel prices.

Electricity demand is set to increase at levels equivalent to adding a new Japan to the world each year, the International Energy Agency said

Ulta Beauty Inc. announced a new $3 billion share buyback authorization on Wednesday and said it plans to open 200 new stores over the next three years.

Analysts drew contrasts with Nike’s struggling performance after Adidas reported another beat-and-raise quarter.

Data and technology company Verisk Analytics Inc. VRSK said Wednesday it estimates the insured losses to onshore property from Hurricane Milton could range from $30 billion to $50 billion.

Sanitation is a major issue for cruise ships.

Mortgage applications fell 17% in the past week, the Mortgage Bankers Association said.

Crude futures were slightly lower early Wednesday, drifting to the downside a day after a rout sparked by news reports that Israel won’t attack Iran’s oil facilities.

One leading hedge fund says it’s not just tech stocks with nosebleed valuations.